Inducing superoxide production in human macrophages through SOD inhibition appears to be a valuable therapeutic alternative, considering current first-line treatment of leishmaniasis with pentavalent antimonials is associated with significant toxicity and worldwide increasing resistance [4], [6], [8]–[9]. This evidence concerns the gene SOD1 and leishmaniasis.